Sustained improvement of surgical scar appearance one year after early intervention with nonablative fractional laser treatment: a randomized controlled split-wound trial

The British Journal of Dermatology
G L GroveK E Karmisholt

Abstract

Early laser treatment during wound healing has increasingly gained focus to improve scar formation1 . The majority of trials addressing early laser intervention for improving scar formation present short follow-up time of 1-3 months2 . Considering the pathophysiology of scar formation, a scar is not mature until a year post-injury. Thus, the effect of early laser treatment should be evaluated at least one year after scar intervention, and knowledge about long-term effect is lacking3-7 .

References

Jan 22, 2003·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Keyvan NouriGeorge W Elgart
Jan 30, 2009·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Jun-Ho ChoeWon-Serk Kim
Jan 29, 2010·Aesthetic Plastic Surgery·Alexandre CaponSerge Mordon
Sep 10, 2010·Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology·F M Leclère, Serge R Mordon
Feb 9, 2018·Journal of the European Academy of Dermatology and Venereology : JEADV·K E KarmisholtM Haedersdal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.